-

Humana Inc. Reschedules Fourth Quarter 2023 Earnings Call to Thursday, January 25, at 9:00 a.m. E.T.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2023 (4Q23), as well as prepared management remarks (in PDF format), on Thursday, January 25, 2024, at approximately 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024.

The call was originally scheduled for Monday, February 5, but was rescheduled to provide a more timely update on the company’s performance and 2024 guidance.

To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4ed0098679fd435e8af0ab344fa47655 .

Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique registrant ID.

A webcast of the 4Q23 earnings call may also be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/.

The company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call. For those unable to participate in the live event, the virtual presentation archive will be available in the Historical Webcasts and Presentations section of the Investor Relations page at https://humana.gcs-web.com/, approximately two hours following the live webcast.

The company’s 4Q23 earnings news release is expected to include financial measures that are not in accordance with Generally Accepted Accounting Principles (GAAP). A reconciliation of non-GAAP financial measures to financial results under GAAP, as well as management’s reasons for including non-GAAP financial measures, will be included in the company’s 4Q23 earnings news release, a copy of which will be available on the Investor Relations page of www.humana.com on January 25, 2024.

About Humana

Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Lisa Stoner
Humana Investor Relations
(502) 580-2652
e-mail: lstamper@humana.com

Mark Taylor
Humana Corporate Communications
(317) 753-0345
e-mail: mtaylor108@humana.com

More News From Humana Inc.

Humana Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced the expiration and final results of its previously announced cash tender offers (collectively, the “Offers”) to purchase the outstanding 2.150% Senior Notes due February 3, 2032 (the “February 2032 Notes”), 3.125% Senior Notes due August 15, 2029 (the “August 2029 Notes”), 3.700% Senior Notes due March 23, 2029 (the “March 2029 Notes”), 4.875% Senior Notes due April 1, 2030 (the “April 2030 Note...

Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 9, 2026 (the “Offer to Purchase”). The Notes offered to be...

Humana Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) (“Humana”, “we”, or “our”) today announced that it has commenced cash tender offers (collectively, the “Offers”) to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated November 9, 2026 (the “Offer to Purchase”). The Notes offered to be purchased in the Offers, in the order of acceptance priority, are the 2.150% Senior Notes due 2032; 3.125% Sen...
Back to Newsroom